130 related articles for article (PubMed ID: 20012410)
1. Murine model of pneumococcal pneumonia.
Medina E
Methods Mol Biol; 2010; 602():405-10. PubMed ID: 20012410
[TBL] [Abstract][Full Text] [Related]
2. Murine models of pneumococcal pneumonia and their applicability to the study of tissue-directed antimicrobials.
Nuermberger E
Pharmacotherapy; 2005 Dec; 25(12 Pt 2):134S-139S. PubMed ID: 16305283
[TBL] [Abstract][Full Text] [Related]
3. Increase of apoptosis in a murine model for severe pneumococcal pneumonia during influenza A virus infection.
Kosai K; Seki M; Tanaka A; Morinaga Y; Imamura Y; Izumikawa K; Kakeya H; Yamamoto Y; Yanagihara K; Tomono K; Kohno S
Jpn J Infect Dis; 2011; 64(6):451-7. PubMed ID: 22116322
[TBL] [Abstract][Full Text] [Related]
4. Effect of anesthetics on pathogenesis of experimentally induced murine pneumococcal pneumonia.
Rubins JB; Charboneau D
Comp Med; 2000 Jun; 50(3):292-5. PubMed ID: 10894495
[TBL] [Abstract][Full Text] [Related]
5. Streptococcus pneumoniae: does antimicrobial resistance matter?
Lynch JP; Zhanel GG
Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
[TBL] [Abstract][Full Text] [Related]
6. Characterization of S. pneumoniae pneumonia-induced multiple organ dysfunction syndrome: an experimental mouse model of gram-positive sepsis.
Andonegui G; Goring K; Liu D; McCafferty DM; Winston BW
Shock; 2009 Apr; 31(4):423-8. PubMed ID: 18827750
[TBL] [Abstract][Full Text] [Related]
7. Protease activated receptor 4 limits bacterial growth and lung pathology during late stage Streptococcus pneumoniae induced pneumonia in mice.
de Stoppelaar SF; Van't Veer C; van den Boogaard FE; Nieuwland R; Hoogendijk AJ; de Boer OJ; Roelofs JJ; van der Poll T
Thromb Haemost; 2013 Sep; 110(3):582-92. PubMed ID: 23783078
[TBL] [Abstract][Full Text] [Related]
8. Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy.
Lynch JP; Zhanel GG
Semin Respir Crit Care Med; 2005 Dec; 26(6):575-616. PubMed ID: 16388429
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
Feldman C
J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
[TBL] [Abstract][Full Text] [Related]
10. Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia.
Rijneveld AW; Weijer S; Bresser P; Florquin S; Vlasuk GP; Rote WE; Spek CA; Reitsma PH; van der Zee JS; Levi M; van der Poll T
Crit Care Med; 2006 Jun; 34(6):1725-30. PubMed ID: 16625114
[TBL] [Abstract][Full Text] [Related]
11. Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice.
Rijneveld AW; Weijer S; Florquin S; Speelman P; Shimizu T; Ishii S; van der Poll T
J Infect Dis; 2004 Feb; 189(4):711-6. PubMed ID: 14767826
[TBL] [Abstract][Full Text] [Related]
12. Important role for CC chemokine ligand 2-dependent lung mononuclear phagocyte recruitment to inhibit sepsis in mice infected with Streptococcus pneumoniae.
Winter C; Herbold W; Maus R; Länger F; Briles DE; Paton JC; Welte T; Maus UA
J Immunol; 2009 Apr; 182(8):4931-7. PubMed ID: 19342672
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a young mouse model and identification of an allelic variation of zmpB in complicated pneumonia caused by Streptococcus pneumoniae.
Hsieh YC; Tsao PN; Chen CL; Lin TL; Lee WS; Shao PL; Lee CY; Hsueh PR; Huang LM; Wang JT
Crit Care Med; 2008 Apr; 36(4):1248-55. PubMed ID: 18379252
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-related protein-8/14 facilitates bacterial growth during pneumococcal pneumonia.
Achouiti A; Vogl T; Endeman H; Mortensen BL; Laterre PF; Wittebole X; van Zoelen MA; Zhang Y; Hoogerwerf JJ; Florquin S; Schultz MJ; Grutters JC; Biesma DH; Roth J; Skaar EP; van 't Veer C; de Vos AF; van der Poll T
Thorax; 2014 Nov; 69(11):1034-42. PubMed ID: 25179663
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide exerts distinct effects in local and systemic infections with Streptococcus pneumoniae.
Kerr AR; Wei XQ; Andrew PW; Mitchell TJ
Microb Pathog; 2004 Jun; 36(6):303-10. PubMed ID: 15120156
[TBL] [Abstract][Full Text] [Related]
16. Streptococcus pneumoniae and Staphylococcus aureus pneumonia induce distinct metabolic responses.
Slupsky CM; Cheypesh A; Chao DV; Fu H; Rankin KN; Marrie TJ; Lacy P
J Proteome Res; 2009 Jun; 8(6):3029-36. PubMed ID: 19368345
[TBL] [Abstract][Full Text] [Related]
17. [Models of experimental Haemophilus influenzae and Streptococcus pneumoniae pneumonia in mice].
Bédos JP; Vallée E
Rev Pneumol Clin; 1992; 48(3):95-100. PubMed ID: 1439468
[TBL] [Abstract][Full Text] [Related]
18. Activation of neutrophils and inhibition of the proinflammatory cytokine response by endogenous granulocyte colony-stimulating factor in murine pneumococcal pneumonia.
Knapp S; Hareng L; Rijneveld AW; Bresser P; van der Zee JS; Florquin S; Hartung T; van der Poll T
J Infect Dis; 2004 Apr; 189(8):1506-15. PubMed ID: 15073689
[TBL] [Abstract][Full Text] [Related]
19. Pneumonia due to resistant Streptococcus pneumoniae.
Täuber MG
Schweiz Med Wochenschr; 2000 Dec; 130(49):1873-9. PubMed ID: 11153392
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of recombinant human granulocyte colony-stimulating factor in a murine model of pneumococcal pneumonia: effects of lung inflammation and timing of treatment.
Dallaire F; Ouellet N; Simard M; Bergeron Y; Bergeron MG
J Infect Dis; 2001 Jan; 183(1):70-7. PubMed ID: 11087202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
